|
US4609675A
(en)
|
1984-08-17 |
1986-09-02 |
The Upjohn Company |
Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
|
|
IE62126B1
(en)
|
1986-03-12 |
1994-12-14 |
American Cyanamid Co |
Macrolide compounds
|
|
DK39892D0
(da)
|
1992-03-25 |
1992-03-25 |
Bernard Thorens |
Peptid
|
|
US5869602A
(en)
|
1995-03-17 |
1999-02-09 |
Novo Nordisk A/S |
Peptide derivatives
|
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
US5650386A
(en)
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
|
IL128332A0
(en)
|
1996-08-30 |
2000-01-31 |
Novo Nordisk As |
GLP-1 derivatives
|
|
US5773647A
(en)
|
1997-02-07 |
1998-06-30 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
JP2003522099A
(ja)
|
1998-02-27 |
2003-07-22 |
ノボ ノルディスク アクティーゼルスカブ |
遅延作用プロファイルを有するｇｌｐ−１のｇｌｐ−１誘導体及びエキセンジン
|
|
EP1061946B1
(en)
|
1998-02-27 |
2004-04-28 |
Novo Nordisk A/S |
Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
|
|
JP2002512175A
(ja)
|
1998-02-27 |
2002-04-23 |
ノボ ノルディスク アクティーゼルスカブ |
Ｇｌｐ−１類似体の誘導体類
|
|
EP1062240B1
(en)
|
1998-02-27 |
2010-04-28 |
Novo Nordisk A/S |
N-terminally modified glp-1 derivatives
|
|
SE9802080D0
(sv)
|
1998-06-11 |
1998-06-11 |
Hellstroem |
Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
|
|
CA2361716C
(en)
|
1999-02-05 |
2009-04-28 |
Emisphere Technologies, Inc. |
Method of preparing alkylated salicylamides
|
|
US7658938B2
(en)
|
1999-02-22 |
2010-02-09 |
Merrion Reasearch III Limited |
Solid oral dosage form containing an enhancer
|
|
AU3240900A
(en)
|
1999-02-22 |
2000-09-04 |
Emisphere Holdings, Inc. |
Solid oral dosage form containing heparin or a heparinoid in combination with a carrier
|
|
CA2363123C
(en)
|
1999-02-22 |
2011-09-06 |
Kenneth Iain Cumming |
Solid oral dosage form containing an enhancer
|
|
GB9923436D0
(en)
|
1999-10-04 |
1999-12-08 |
American Home Prod |
Pharmaceutical compositions
|
|
US6793934B1
(en)
|
1999-12-08 |
2004-09-21 |
Shire Laboratories, Inc. |
Solid oral dosage form
|
|
WO2001092206A1
(en)
|
2000-06-02 |
2001-12-06 |
Emisphere Technologies, Inc. |
Method of preparing salicylamides
|
|
US7049283B2
(en)
|
2000-12-06 |
2006-05-23 |
Novartis Ag |
Pharmaceutical compositions for the oral delivery of pharmacologically active agents
|
|
RU2003131338A
(ru)
|
2001-03-27 |
2005-02-10 |
Рэнбакси Лабораториз Лимитед (In) |
Стабильная фармацевтическая композиция на основе правастатина
|
|
RU2262922C2
(ru)
|
2001-05-15 |
2005-10-27 |
Уорнер-Ламберт Компани Ллс |
Способ прессования для получения лекарственной формы фенитоина натрия
|
|
US20030068356A1
(en)
|
2001-07-10 |
2003-04-10 |
Pather S. Indiran |
Sequential drug delivery systems
|
|
AU2002352974A1
(en)
|
2001-11-29 |
2003-06-10 |
Emisphere Technologies, Inc. |
Formulations for oral administration of cromolyn sodium
|
|
BR0307331A
(pt)
|
2002-02-01 |
2004-12-07 |
Pfizer Prod Inc |
Formulações granuladas a seco de azitromicina
|
|
CN1332711C
(zh)
|
2002-02-20 |
2007-08-22 |
埃米球科技有限公司 |
施用glp－1分子的方法
|
|
JP2004131398A
(ja)
*
|
2002-10-08 |
2004-04-30 |
Taihei Chemical Industrial Co Ltd |
錠剤用滑沢剤
|
|
BRPI0411165A
(pt)
|
2003-05-14 |
2006-07-11 |
Emisphere Tech Inc |
composição farmacêutica, forma de unidade de dosagem e métodos para preparar seu uso
|
|
ES2330638T3
(es)
|
2003-07-11 |
2009-12-14 |
Novartis Ag |
Composiciones farmaceuticas dosificadas en forma oral que contienen un agente de suministro en forma micronizada.
|
|
KR101241862B1
(ko)
|
2003-09-19 |
2013-03-13 |
노보 노르디스크 에이/에스 |
신규 ｇｌｐ-1 유도체
|
|
JP2007537142A
(ja)
|
2003-12-18 |
2007-12-20 |
ノボ ノルディスク アクティーゼルスカブ |
アルブミン様物質に結合した新規のｇｌｐ−１類似物
|
|
MXPA06006745A
(es)
|
2003-12-18 |
2006-08-18 |
Novo Nordisk As |
Compuestos glp-1 novedosos.
|
|
US20060286129A1
(en)
|
2003-12-19 |
2006-12-21 |
Emisphere Technologies, Inc. |
Oral GLP-1 formulations
|
|
WO2005099672A1
(en)
|
2004-04-13 |
2005-10-27 |
Ranbaxy Laboratories Limited |
A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
|
|
WO2005107773A2
(en)
*
|
2004-05-06 |
2005-11-17 |
Emisphere Technologies, Inc. |
Solid dosage form of wetted heparin
|
|
CN102001962B
(zh)
|
2004-05-06 |
2013-04-03 |
爱密斯菲尔科技公司 |
N-[8-(2-羟基苯甲酰基)氨基]辛酸一钠的晶体的多晶
|
|
NZ551196A
(en)
|
2004-05-14 |
2010-08-27 |
Emisphere Tech Inc |
Compounds and compositions for delivering active agents
|
|
CN1767818A
(zh)
|
2004-05-31 |
2006-05-03 |
三亚药品株式会社 |
含β－内酰胺抗生素的分散片剂及其制备方法
|
|
CN101010339B
(zh)
|
2004-07-02 |
2011-11-09 |
布里斯托尔-迈尔斯斯奎布公司 |
人类胰高血糖素样肽-1调节剂及它们在治疗糖尿病及相关病况中的用途
|
|
MXPA06015049A
(es)
|
2004-07-08 |
2007-02-08 |
Novo Nordisk As |
Marcadores prolongadores de polipeptidos que comprenden una porcion tetrazol.
|
|
WO2006124047A2
(en)
|
2004-08-13 |
2006-11-23 |
Emisphere Technologies, Inc. |
Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
|
|
US7893017B2
(en)
|
2004-10-07 |
2011-02-22 |
Novo Nordisk A/S |
Protracted GLP-1 compounds
|
|
US8030273B2
(en)
|
2004-10-07 |
2011-10-04 |
Novo Nordisk A/S |
Protracted exendin-4 compounds
|
|
MX2007006635A
(es)
|
2004-12-03 |
2007-06-19 |
Merck & Co Inc |
Formulacion farmaceutica de inhibidores dela carboxamida vih integrasa que contienen una composicion que controla la velocidad de liberacion.
|
|
ES2540929T3
(es)
|
2005-02-01 |
2015-07-14 |
Emisphere Technologies, Inc. |
Sistema de administración de retención gástrica y liberación controlada
|
|
TWI372629B
(en)
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
JP5755398B2
(ja)
|
2005-03-18 |
2015-07-29 |
ノヴォ ノルディスク アー／エス |
伸長されたｇｌｐ−１化合物
|
|
EP1863449A2
(en)
|
2005-03-28 |
2007-12-12 |
Dexcel Pharma Technologies Ltd. |
Controlled absorption of statins in the intestine
|
|
US20070049557A1
(en)
|
2005-08-24 |
2007-03-01 |
Hashim Ahmed |
Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers
|
|
RU2469709C2
(ru)
|
2005-11-17 |
2012-12-20 |
Новартис Аг |
Фармацевтическая композиция
|
|
KR101191322B1
(ko)
|
2006-04-07 |
2012-10-16 |
메리온 리서치 Ⅲ 리미티드 |
증진제를 함유하는 고형 경구용 투여 제형
|
|
WO2007121318A2
(en)
|
2006-04-12 |
2007-10-25 |
Emisphere Technologies, Inc. |
Formulations for delivering insulin
|
|
EP2040731A4
(en)
|
2006-06-09 |
2010-05-19 |
Merrion Res Iii Ltd |
SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING AN ACTIVATOR
|
|
JP5475443B2
(ja)
|
2006-06-28 |
2014-04-16 |
エミスフェアー・テクノロジーズ・インク |
硝酸ガリウム製剤
|
|
ES2296529B1
(es)
|
2006-08-07 |
2009-04-01 |
Laboratorios Farmaceuticos Rovi, S.A. |
Composicion farmaceutica con promotores de absorcion.
|
|
US20090318353A1
(en)
|
2006-08-25 |
2009-12-24 |
Novo Nordisk A/S |
Acylated Exendin-4 Compounds
|
|
CA2662080C
(en)
|
2006-09-07 |
2012-07-17 |
F. Hoffmann-La Roche Ag |
A process for the manufacture of snac (salcaprozate sodium)
|
|
WO2008039351A2
(en)
|
2006-09-22 |
2008-04-03 |
Novartis Ag |
Method of manufacturing tablets containing pharmacologically active agents
|
|
WO2008070547A1
(en)
|
2006-12-01 |
2008-06-12 |
Emisphere Technologies Inc. |
Improved acyclovir formulations
|
|
KR20150091536A
(ko)
|
2007-03-02 |
2015-08-11 |
노파르티스 아게 |
칼시토닌의 경구 투여
|
|
CN101842101A
(zh)
|
2007-08-29 |
2010-09-22 |
加利福尼亚大学董事会 |
水杨酰苯胺修饰的肽用作口服治疗剂
|
|
WO2009030774A1
(en)
|
2007-09-05 |
2009-03-12 |
Novo Nordisk A/S |
Truncated glp-1 derivatives and their therapeutical use
|
|
US20100261637A1
(en)
|
2007-09-05 |
2010-10-14 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
|
EP2190872B1
(en)
|
2007-09-05 |
2018-03-14 |
Novo Nordisk A/S |
Glucagon-like peptide-1 derivatives and their pharmaceutical use
|
|
JP5868594B2
(ja)
|
2007-10-16 |
2016-02-24 |
バイオコン・リミテッドＢｉｏｃｏｎ Ｌｉｍｉｔｅｄ |
経口投与可能な固形医薬組成物及びそのプロセス
|
|
NZ585080A
(en)
|
2007-11-02 |
2012-05-25 |
Emisphere Tech Inc |
Composition comprising Vitamin B12 and N-[8-(2-hydroxybenzoyl) amino ]caprylic acid and salts thereof for treating Vitamin B12 deficiency
|
|
US20090124639A1
(en)
*
|
2007-11-06 |
2009-05-14 |
Emisphere Technologies Inc. |
valacyclovir formulations
|
|
US20100317057A1
(en)
|
2007-12-28 |
2010-12-16 |
Novo Nordisk A/S |
Semi-recombinant preparation of glp-1 analogues
|
|
RU2494755C2
(ru)
*
|
2008-08-18 |
2013-10-10 |
Интера Био Лтд. |
Способы и композиции для перорального введения белков
|
|
EP2395988A2
(en)
*
|
2009-02-13 |
2011-12-21 |
Boehringer Ingelheim International GmbH |
Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
|
|
AU2010339907A1
(en)
|
2009-12-16 |
2012-07-05 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
|
US20110182985A1
(en)
|
2010-01-28 |
2011-07-28 |
Coughlan David C |
Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
|
|
WO2011109787A1
(en)
|
2010-03-05 |
2011-09-09 |
Conjuchem, Llc |
Methods of administering insulinotropic peptides
|
|
GB2478849A
(en)
|
2010-03-16 |
2011-09-21 |
Chiasma Inc |
Improved pharmecutical compositions and methods of delivery
|
|
JP2013523833A
(ja)
|
2010-04-07 |
2013-06-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
３−（６−（１−（２，２−ジフルオロベンゾ［ｄ］［１，３］ジオキソール−５−イル）シクロプロパンカルボキサミド）−３−メチルピリジン−２−イル）安息香酸の医薬組成物およびその投与
|
|
CA3070513C
(en)
|
2010-05-05 |
2023-01-03 |
Boehringer Ingelheim International Gmbh |
A dpp-4 inhibitor for use in treatment of skin-alterations or necrosis
|
|
DE202010015867U1
(de)
|
2010-11-25 |
2011-05-05 |
Buchhalter, Thomas |
Elektromechanische Halterung zur Aufnahme von Navigations- und Kommunikationsgeräte im KFZ
|
|
MX377589B
(es)
|
2010-12-16 |
2025-03-10 |
Novo Nordisk As |
Composiciones sólidas que comprenden agonista de glp-1 y sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico.
|
|
CN104203266B
(zh)
|
2012-03-22 |
2017-12-26 |
诺和诺德股份有限公司 |
Glp‑1肽组合物及其制备
|
|
EP3542790B1
(en)
|
2012-03-22 |
2023-09-13 |
Novo Nordisk A/S |
Compositions comprising a delivery agent and preparation thereof
|
|
JP6517690B2
(ja)
|
2012-06-20 |
2019-05-22 |
ノヴォ ノルディスク アー／エス |
ペプチド及び送達剤を含む錠剤製剤
|
|
JP6672140B2
(ja)
|
2013-05-02 |
2020-03-25 |
ノヴォ ノルディスク アー／エス |
Ｇｌｐ−１化合物の経口投薬
|